 |
1A8K |
CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2\' POSITION OF SUBSTRATES |
C |
AB |
Acid proteases |
|
 |
1A94 |
STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES |
C |
AB |
Acid proteases |
|
 |
1AVF |
ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH |
P |
A |
|
|
 |
1BAI |
Crystal structure of Rous sarcoma virus protease in complex with inhibitor |
C |
A |
Acid proteases |
|
 |
1DPJ |
THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR |
B |
A |
Acid proteases |
|
 |
1EPL |
A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA |
I |
E |
Acid proteases |
|
 |
1EPM |
A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA |
I |
E |
Acid proteases |
|
 |
1ER8 |
THE ACTIVE SITE OF ASPARTIC PROTEINASES |
I |
E |
Acid proteases |
|
 |
1F7A |
HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE. |
P |
A |
Acid proteases |
|
 |
1G0V |
THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV |
B |
A |
Acid proteases |
|
 |
1KJ7 |
SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
P |
A |
Acid proteases |
|
 |
1KJF |
SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
P |
A |
Acid proteases |
|
 |
1KJG |
SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
P |
A |
Acid proteases |
|
 |
1KJH |
SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
P |
A |
Acid proteases |
|
 |
1MT7 |
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy |
P |
A |
Acid proteases |
|
 |
1MT8 |
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy |
P |
A |
Acid proteases |
|
 |
1MT9 |
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy |
P |
A |
Acid proteases |
|
 |
1SP5 |
Crystal structure of HIV-1 protease complexed with a product of autoproteolysis |
I |
A |
|
|
 |
1TSQ |
CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT |
P |
A |
Acid proteases |
|
 |
1TSU |
CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT |
P |
A |
Acid proteases |
|
 |
2FNS |
Crystal structure of wild-type inactive (D25N) HIV-1 protease complexed with wild-type HIV-1 NC-p1 substrate. |
P |
A |
Acid proteases |
|
 |
2FNT |
Crystal structure of a drug-resistant (V82A) inactive (D25N) HIV-1 protease complexed with AP2V variant of HIV-1 NC-p1 substrate. |
P |
A |
Acid proteases |
|
 |
2MIP |
CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES |
E |
A |
Acid proteases |
|
 |
2NPH |
Crystal structure of HIV1 protease in situ product complex |
T |
SA |
Acid proteases |
|
 |
2NXD |
Structure of HIV-1 protease D25N complexed with rt-rh analogue peptide GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA |
P |
A |
|
|
 |
2NXL |
Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA |
P |
A |
|
|
 |
2NXM |
Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA |
P |
A |
|
|
 |
4ER4 |
HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES |
I |
E |
Acid proteases |
|